R. Baruchello

发表

Mild and efficient capture and functionalisation of CO2 using silver(I) oxide and application to 13C-labelled dialkyl carbonates

G. Tunbridge, R. Baruchello, Lorenzo Caggiano, 2013 .

New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.

Maria Paola Costi, F. Esposito, R. Baruchello, 2018, Bioorganic & medicinal chemistry letters.

Pro-apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro

C. Scapoli, R. Gambari, M. Borgatti, 2020, Oncology letters.

1,5,7-Triazabicyclo[4.4.0]dec-1-ene (TBD), 7-methyl-TBD (MTBD) and the polymer-supported TBD (P-TBD): three efficient catalysts for the nitroaldol (Henry) reaction and for the addition of dialkyl phosphites to unsaturated systems

R. Baruchello, R. Rondanin, D. Simoni, 2000 .

Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90.

G. Giannini, R. Baruchello, C. Pisano, 2011, Journal of medicinal chemistry.

Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor

R. Baruchello, L. Hsu, R. Rondanin, 2012, Investigational New Drugs.

Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.

R. Baruchello, M. Roberti, N. D’alessandro, 2001, Journal of medicinal chemistry.

Stilbene 5c, a microtubule poison with vascular disrupting properties that induces multiple modes of growth arrest and cell death.

D. Gewirtz, Xu Di, E. Schwartz, 2013, Biochemical pharmacology.

Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.

R. Baruchello, M. Roberti, Daniela Pizzirani, 2003, Journal of medicinal chemistry.

Pig liver esterase (PLE)-mediated resolution of N-substituted 4-benzoyloxy-3-carbomethoxypiperidines: a convenient preparation of 4-hydroxy- and 4-benzoyloxy-3-carbomethoxypiperidines in enantiomerically pure form

V. Andrisano, R. Baruchello, C. Bertucci, 2000 .

4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors.

G. Giannini, R. Baruchello, L. Vesci, 2014, European journal of medicinal chemistry.

Novel combretastatin analogues endowed with antitumor activity.

G. Giannini, M. Rizzi, R. Baruchello, 2006, Journal of medicinal chemistry.

Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.

G. Giannini, R. Baruchello, T. Bernardi, 2017, Bioorganic & medicinal chemistry letters.

Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities.

R. Baruchello, P. Poma, M. Labbozzetta, 2009, Chemico-biological interactions.

Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells.

G. Giannini, N. Gebbia, R. Baruchello, 2005, Journal of medicinal chemistry.

1,5,7‐Triazabicyclo[4.4.0]dec‐1‐ene (TBD), 7‐Methyl‐TBD (MTBD) and the Polymer‐Supported TBD (P‐TBD): Three Efficient Catalysts for the Nitroaldol (Henry) Reaction and for the Addition of Dialkyl Phosphites to Unsaturated Systems.

R. Baruchello, R. Rondanin, D. Simoni, 2000 .

Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.

G. Giannini, M. Rizzi, R. Baruchello, 2008, Journal of medicinal chemistry.

A practical entry to C18-constrained-E-ring analogues of methyllycaconitine (MLA): a concise new stereoselective approach to 8-oxa-decahydroisoquinolines accompanied by a simple microwaves-assisted synthesis of the succinimidobenzoate appendage of MLA

R. Baruchello, R. Rondanin, D. Simoni, 2005 .

Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.

M. Rizzi, R. Baruchello, P. Poma, 2008, Bioorganic & medicinal chemistry letters.

Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.

G. Giannini, N. Gebbia, R. Baruchello, 2005, Journal of medicinal chemistry.

Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism.

E. Novellino, N. Gebbia, F. Dieli, 2008, Journal of medicinal chemistry.

Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptotic properties.

M. Rizzi, R. Baruchello, M. Tolomeo, 2008, Journal of medicinal chemistry.

A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol

G. Giannini, R. Baruchello, M. Roberti, 2003 .

Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells.

R. Baruchello, M. Roberti, N. D’alessandro, 2000, Bioorganic & medicinal chemistry letters.

Curcumin as a Possible Lead Compound against Hormone‐Independent, Multidrug‐Resistant Breast Cancer

M. Rizzi, R. Baruchello, L. Inguglia, 2009, Annals of the New York Academy of Sciences.

Retinoic acid and analogs as potent inducers of differentiation and apoptosis. New promising chemopreventive and chemotherapeutic agents in oncology

R. Baruchello, M. Roberti, N. D’alessandro, 2001 .

Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives.

R. Baruchello, R. Romagnoli, M. Tolomeo, 2014, Bioorganic & medicinal chemistry letters.

Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells

S. Dakshanamurthy, E. Rosen, R. Baruchello, 2009, Experimental & Molecular Medicine.

Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth.

J. Guh, R. Baruchello, L. Hsu, 2016, Biochemical pharmacology.

Versatile synthesis of new cytotoxic agents structurally related to hemiasterlins.

R. Baruchello, R. Rondanin, D. Simoni, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.

K. Varani, R. Baruchello, S. Merighi, 2005, Journal of medicinal chemistry.

Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.

N. Gebbia, F. Dieli, R. Baruchello, 2006, Bioorganic & medicinal chemistry letters.

Design, synthesis and biological evaluation of novel stilbene-based antitumor agents.

G. Kellogg, R. Baruchello, A. Tripathi, 2009, Bioorganic & medicinal chemistry.

Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter.

K. Varani, R. Baruchello, S. Merighi, 2001, Bioorganic & medicinal chemistry letters.

Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity

G. Kellogg, R. Baruchello, A. Tripathi, 2009, Journal of enzyme inhibition and medicinal chemistry.

A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach.

L. Ferraro, R. Baruchello, A. Dalpiaz, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.

G. Giannini, R. Baruchello, T. Bernardi, 2017, Bioorganic & medicinal chemistry letters.

A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach.

L. Ferraro, R. Baruchello, A. Dalpiaz, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.